Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 631 AL 645

Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach

Kumar S, Mahajan A, Ambatwar R, Khatik GL.

Curr Med Chem. 2024;31(37):6032-6062. doi: 10.2174/0109298673264076230921065945.

Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease

Khan J, Yadav S, Alam MA.

Infect Disord Drug Targets. 2024;24(3):e231023222565. doi: 10.2174/0118715265254985231012065058.

γ-Secretase: once and future drug target for Alzheimer's disease

Wolfe MS.

Expert Opin Drug Discov. 2024 Jan-Jun;19(1):5-8. doi: 10.1080/17460441.2023.2277350. Epub 2024 Jan 8.

Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease

Li L, Wang F, Jia X, Yao L, Liu Y.

Mini Rev Med Chem. 2024;24(17):1590-1601. doi: 10.2174/0113895575263783231009051957.

Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review

Basso L, Fagundes SC, Staudt T, da Rosa K, Langaro E, Omidian H, Bertol CD.

CNS Neurol Disord Drug Targets. 2024;23(9):1075-1084. doi: 10.2174/0118715273275957231102044934.

Alzheimer's Disease and Cancer: Common Targets

Yang X, Dai J, Wu C, Liu Z.

Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.

Efficacy analysis of three brain stimulation techniques for Alzheimer's disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain stimulation

Huang P, Lin L, Zhang J, Cheng Y, Pan X.

Expert Rev Neurother. 2024 Jan-Jun;24(1):117-127. doi: 10.1080/14737175.2023.2293225. Epub 2024 Jan 8.

Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight

Al-Horani RA.

Pharm Pat Anal. 2024;13(4-6):131-137. doi: 10.1080/20468954.2024.2363657. Epub 2024 Jun 20.

Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics

Dhapola R, Beura SK, Sharma P, Singh SK, HariKrishnaReddy D.

Mol Biol Rep. 2024 Jan 2;51(1):48. doi: 10.1007/s11033-023-09021-z.

Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies

Seo DO, Holtzman DM.

Exp Mol Med. 2024 Feb;56(1):86-94. doi: 10.1038/s12276-023-01146-2. Epub 2024 Jan 4.

Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease

Cao Q, Dong P, Han H.

Psychogeriatrics. 2024 Mar;24(2):443-457. doi: 10.1111/psyg.13051. Epub 2024 Jan 3.

Radiotherapy for non-cancer diseases: benefits and long-term risks

Thariat J, Little MP, Zablotska LB, Samson P, O'Banion MK, Leuraud K, Bergom C, Girault G, Azimzadeh O, Bouffler S, Hamada N.

Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5.

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM.

Ann Neurol. 2024 Apr;95(4):625-634. doi: 10.1002/ana.26864. Epub 2024 Jan 5.

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang X, Li H, Sheng Y, He B, Liu Z, Li W, Yu S, Wang J, Zhang Y, Chen J, Qin L, Meng X.

Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias